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Abstract
Background: Primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade B cell lymphoma
that is a type of non-Hodgkin lymphoma and a type of primary pulmonary malignant lymphoma. MALT lymphomas
affecting the lung show various findings on chest computed tomography, which range from typical nodules or areas of
consolidation to findings that are extremely rare in pulmonary MALT lymphomas, such as pure ground-glass opacities
throughout the lung.
Case presentation: A 35-year-old woman was found to have a few shadows with ground glass opacities on
chest computed tomography (CT) in 2012. A shadow in right S10 that was initially very small increased in
size over time, and was 14 × 8 mm in 2015. Other shadows also appeared. Because lung adenocarcinoma was
suspected, the patient underwent video-assisted thoracoscopic surgery with a right wedge resection of the
lower lobe that included the largest nodule in S10 and other nodules. Histopathological examination of the
right S10 and other lesions revealed small- or medium-sized lymphocyte-like cells that were located in the
alveolar interseptal spaces. The alveolar walls remained intact. Immunohistochemical staining showed that
tumor cells were positive for CD20, CD79a, and BCL2 expression. The lesions were diagnosed as extranodal
marginal zone B-cell lymphoma of MALT.
Conclusions: We think that the ground glass opacities on CT were accounted for by MALT lesions that contained
intact alveolar air spaces. The patient has remained well during 12 months of follow up after surgery. Although she did
not receive chemotherapy because the MALT lymphoma lesions have been stable without progression, the patient is
kept under close observation because of potential progression of the disease.
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Background
Pulmonary extranodal marginal zone lymphoma of
mucosa-associated lymphoid tissue (MALT) is a type of
primary pulmonary malignant lymphoma with monoclonal
B cells, and infiltrates the bronchiolar mucosal epithelium,
forming lymphoepithelial lesions [1]. Patients with MALT
lymphoma may have nonspecific symptoms and can also
be asymptomatic [2]. Chest computed tomography (CT)
findings of MALT lymphomas occurring in the lung range
from typical nodules or areas of consolidation to findings
that are extremely rare, such as pure ground-glass opacities
(GGOs) [2]. Here, we report a patient with growth and
many GGOs.
Case presentation
A 35-year-old woman was found to have a few shadows
with GGOs on chest CT in 2012. She was monitored
and a shadow in right S10 was found to increase in size,
which suggested lung adenocarcinoma. The patient was
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referred to our hospital for further evaluation. The pa-
tient had a history of bronchial asthma. The shadow in
right S10 had increased to 14 × 8 mm by 2015 (Fig. 1).
Other shadows also appeared (Fig. 2). After preoperative
CT-guided marking, the patient underwent video-
assisted thoracoscopic surgery with a right wedge resec-
tion of the lower lobe that included the largest nodule in
S10 and other nodules. Her postoperative course was
uneventful.
Grossly, the surgical specimen contained pale, some-
what yellow lesions (Fig. 3). Histopathological examin-
ation of the right S10 lesion and other nodules revealed
small- or medium-sized lymphocyte-like cells that were
located in the alveolar interseptal spaces. The alveolar
walls remained intact (Fig. 4a, b). Immunohistochemical
staining showed that tumor cells were positive for CD20
(1:400 dilution; DAKO, Carpinteria, CA, USA, Fig. 4c),
CD79a (1:200 dilution; DAKO, Carpinteria, CA, USA),
and BCL2 (1:50 dilution; DAKO, Carpinteria, CA, USA,
Fig. 4d) expression and negative for CD10 (1:50 dilution;
Novocastra, Newcastle upon Tyne, UK), cyclin D1 (1:75
dilution; DAKO, Carpinteria, CA, USA) and CD30 (1:40
dilution; DAKO, Carpinteria, CA, USA). The lesions
were diagnosed as extranodal marginal zone B-cell
lymphoma of MALT. The patient has remained well
during 12 months of follow up after surgery. Although
she did not receive chemotherapy because the MALT
lymphoma lesions have been stable without progression,
the patient is kept under close observation because of
potential progression of the disease.
Discussion
Extranodal lymphomas, frequently found in the gastro-
intestinal tract, occur in less than 5% of patients with




Fig. 1 Chest computed tomography in 2012 revealed a very small shadow with ground glass opacity (arrow) that increased in size over time. a in
2012 (b) in 2015
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Primary pulmonary lymphoma is defined as lymphoma
with involvement of the lung, lobar, or primary bron-
chus, with or without mediastinal involvement, and
no evidence of extrathoracic lymphoma at the time of
diagnosis or for 3 months thereafter [4]. It is an ex-
tremely rare neoplasm, accounting for 0.5% of all pri-
mary pulmonary malignancies [5], 3–4% of extranodal
non-Hodgkin lymphoma, and less than 1% of non-
Hodgkin’s lymphoma [6].
In chest CT, the usual finding of primary pulmonary
MALT lymphoma is bilateral and multiple, nearly all le-
sions contain clear areas corresponding to an intact
bronchial lumen with sometimes distended bronchi, and
less than 10% of patients have bilateral diffuse reticulo-
nodular opacities, atelectasis or pleural effusion [7]. In
our patient, the CT lesions appeared as pure GGOs.
With the increasing use of low-dose screening CT, in-
creasing numbers of small lung cancers with focal GGOs
are being detected [8]. GGO means an area of a homo-
geneous hazy increase in density that does not obscure
the bronchovascular structure in the lung field on thin-
section CT [9]. GGOs have been reported in 0.2–0.5% of
screened populations [9]. Localized GGOs that persist
for months have been reported to correspond to precan-
cerous lesions such as atypical adenomatous hyperplasia
and early-stage adenocarcinomas such as bronchioloal-
veolar carcinoma [9]. Identification and management of
persistent pure GGOs that appear on CT are difficult. In
our patient, after monitoring her by repeated CT im-






Fig. 2 Chest computed tomography in 2015 also revealed multiple shadows with ground glass opacities a, b in right lower lobe, c in right
middle lobe, d in segment 8 of right lower lobe, and e in left upper lobe
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adenocarcinoma. However, pathological findings in our
case revealed pulmonary extranodal marginal zone B-
cell lymphoma of MALT.
Pulmonary MALT lymphoma manifesting as multiple
pure GGOs is extremely rare. In our case, we think that
GGOs on CT were accounted for by MALT lesions that
contained intact alveolar air spaces.
Pulmonary MALT lymphoma usually has an indolent
course, remaining localized in the lung for long periods
before dissemination [10]. Ahmed et al. studied 22 cases
of bronchial-associated lymphoid tissue lymphoma, and
they concluded that bronchial-associated lymphoid tis-
sue lymphoma responds well to local or systemic ther-
apy and has a relatively good prognosis [10]. Troch et al.
performed follow up without treatment for patients with
pulmonary MALT lymphoma. They concluded that it
was a very indolent disease, with the potential for spon-
taneous regression, and that asymptomatic patients with
MALT lymphoma might not require immediate treat-
ment [11]. Because our patient had multiple pulmonary
lesions, complete excision was difficult; we performed
limited thoracoscopic surgical resection for diagnosis
only. Instead of surgical excision or chemotherapy for
our patient, we are monitoring her other bilateral, slow-
growing GGOs. She has remained well during 12 months
of follow up after surgery, and all the lesions are stable
without progression.
Conclusions
We reported a case of pulmonary extranodal marginal
zone B-cell lymphoma of MALT, with CT features of
multiple pure GGOs, which is extremely rare. We think
that the ground glass opacities on CT were accounted
for by MALT lesions that contained intact alveolar air
spaces. The patient has remained well during 12 months
of follow up after surgery. Although she did not receive
chemotherapy because the MALT lymphoma lesions
have been stable without progression, the patient is kept






Fig. 4 a Pathological findings revealed tumor cells that were located in alveolar interseptal spaces. The alveolar walls remained intact. b Tumor
cells showed slight atypia with hyperchromatic nuclei. Lymphoepithelial lesions were observed in the specimen. c Tumor cells were positive for
CD20 expression. d Tumor cells were positive for BCL2 expression
Fig. 3 The surgical specimen revealed a yellowish tumor
Ding et al. Journal of Cardiothoracic Surgery  (2017) 12:2 Page 4 of 5
Abbreviations





This study was supported in part by JSPS KAKENHI Grant Number JP 15K10272.
Availability of data and materials
The data supporting the conclusions of this article are included within
the article.
Authors’ contributions
All authors participated in the design of the case report and coordination,
and helped to draft the manuscript. XD, TM and AI wrote the manuscript. SK,
TA, HO, YH and YS collected clinical data of the patient and analyzed those.
NT and KS carried out the pathological diagnosis and made pathological
figures. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this
case report and any accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of the Journal of Cardiothoracic Surgery.
Ethics approval and consent to participate
Not required.
Disclosures
The authors have no funding, financial relationships, or conflicts of interest
to disclose.
Author details
1Division of Chest Surgery, Toho University School of Medicine, Tokyo, Japan.
2Department of Cardiothoracic Surgery, Affiliated Suzhou Hospital of Nanjing
Medical University, Suzhou, China. 3Shinya Clinic, Kanagawa, Japan.
4Department of Surgical Pathology, Toho University School of Medicine,
Tokyo, Japan.
Received: 2 September 2016 Accepted: 19 January 2017
References
1. Travis WD, Brambilla E, Burke A, Marx A, Nicholson A. WHO Classification of
Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon: IARC; 2015.
2. Noguchi S, Yatera K, Kido T, Ogoshi T, Nagata S, Nishida C, et al. Pulmonary
mucosa-associated lymphoid tissue (MALT) lymphoma with multiple thin-
walled pulmonary cysts: a case report and review of the literature. Intern
Med. 2013;52:2325–9.
3. Halliday T, Baxter G. Lymphoma: pictorial review. I. Eur Radiol. 2003;13:1154–64.
4. Yoshino N, Hirata T, Takeuchi C, Usuda J, Hosone M. A case of primary
pulmonary diffuse large B cell lymphoma diagnosed by transbronchial
biopsy. Ann Thorac Cardiovasc Surg. 2015;21:396–8.
5. Cherian SV, Thampy E, Mauzo SH. Primary pulmonary lymphoma: a case of
‘unresolving pneumonia’. Am J Med. 2014;127:e3–4.
6. Shinoda K, Taki H, Tsuda T, Hayashi R, Nomoto K, Tobe K. Primary pulmonary
lymphoma presenting with multiple lung nodules. Am J Respir Crit Care Med.
2014;190:e30–1.
7. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir
J. 2002;20:750–62.
8. Lu CH, Hsiao CH, Chang YC, Lee JM, Shih JY, Wu LA, et al. Percutaneous
computed tomography-guided coaxial core biopsy for small pulmonary
lesions with ground-glass attenuation. J Thorac Oncol. 2012;7:143–50.
9. Hiramatsu M, Inagaki T, Inagaki T, Matsui Y, Satoh Y, Okumura S, et al.
Pulmonary ground-glass opacity (GGO) lesions–large size and a history of
lung cancer are risk factors for growth. J Thorac Oncol. 2008;3:1245–50.
10. Ahmed S, Kussick SJ, Siddiqui AK, Bhuiya TA, Khan A, Sarewitz S, et al.
Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare
disease. Eur J Cancer. 2004;40:1320–6.
11. Troch M, Streubel B, Petkov V, Turetschek K, Chott A, Raderer M. Does MALT
lymphoma of the lung require immediate treatment? An analysis of 11
untreated cases with long-term follow-up. Anticancer Res. 2007;27:3633–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ding et al. Journal of Cardiothoracic Surgery  (2017) 12:2 Page 5 of 5
